Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver
Effect of Dietary Intervention on Intestinal Microbiota in Patients With Non-alcoholic Fatty Liver Disease
Sponsor: University Hospital, Geneva
Listed as NCT01477307, this observational or N/A phase trial focuses on Non-alcoholic Fatty Liver Disease (NAFLD) and Obesity and remains completed. Sponsored by University Hospital, Geneva, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 2 earlier versions
-
Nov 2017 — Apr 2018 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2 → NA
-
Jan 2017 — Nov 2017 [monthly]
Unknown Status PHASE2
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Geneva
For direct contact, visit the study record on ClinicalTrials.gov .